1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECH
  4. MONOPAR THERAPEUTICS INC
Monopar Therapeutics Inc XNAS: MNPR

Monopar Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

about

Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prev...

Read More
42.66 -0.37 (-0.86%)
2380.23% Gain from 52W Low
13,086
XNAS Volume

XNAS 30 Jul, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Board Meeting
The next board meeting for Monopar Therapeutics Inc is on 08 Aug 2025 for the purpose of Monopar Therapeutics Inc Second Quarter Earnings Results for 2025 See details
Durability score
Not Eligible
-
Valuation Score
Expensive Valuation
4.3 / 100
Momentum Score
Technically Neutral
58.2 / 100
Analyst Price Target
No estimates available

11

S

7

W

4

O

1

T

SWOT Analysis

Monopar Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..